An 18% ROE, Asia-led compounder still priced like a “steady insurer”—Manulife’s re-rating hinges on WAM flows, CRE containment, and India traction.
Overview
Manulife Financial (MFC.TO) is a global life insurance and wealth manager headquartered in Toronto with a major footprint across **Asia, Canada, and the U.S. (John Hancock)**, serving **36M+ customers** and overseeing **$1T+ AUMA**. The 2024–2025 investment narrative is a decisive **portfolio optimization** pivot: exiting or reinsuring legacy, capital-intensive, low-ROE exposures (notably U.S. variable annuities and long-term care) and reallocating toward **higher-ROE, capital-light** businesses with more stable earnings. The operating model is intentionally diversified: Canada provides steady cash flow to fund dividends/buybacks and growth; Asia is the primary growth and margin driver (benefiting from demographics and the rebound of Mainland Chinese Visitors to Hong Kong); Global WAM is the scalable fee engine (currently challenged by outflows); and the U.S. business is being reshaped toward “behavioral insurance” and de-risked through reinsurance. In late 2025, management unveiled a refreshed enterprise strategy emphasizing wealth expansion, **AI-at-scale digitization** for cost efficiency, and longevity/health outcomes—validated by a standout **18.1% Core ROE in Q3 2025**, suggesting the transformation is translating into materially higher-quality profitability.